{"id":"W4406818361","doi":"10.1016/s0140-6736(24)02848-4","title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Medicine; Open label; Colorectal cancer; Microsatellite instability; Oncology; Internal medicine; Metastatic melanoma; Phases of clinical research; Cancer; Randomized controlled trial; Immunotherapy; Clinical trial; Microsatellite; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001499347,0.001915906,0.002654068,0.0003318941,0.0003522142,0.001295951,0.0009718334,0.001985619,0.006675555],"category_scores_gemma":[0.001609472,0.000643659,0.00290188,0.0003076914,0.001045855,0.001221352,0.0004722535,0.003845188,0.001303213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011466,"about_ca_system_score_gemma":0.000895355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001386158,"about_ca_topic_score_gemma":0.003322906,"domain_scores_codex":[0.9995006,0.0002548038,0.00002032588,0.00009189425,0.00003353106,0.00009877588],"domain_scores_gemma":[0.9993235,0.0002163123,0.0001356487,0.00005249992,0.00003503505,0.0002370431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9784056,0.002548464,0.0003373373,0.0006298911,0.001081188,0.0000337248,0.00004594186,0.0003994722,0.00152448,0.0001186641,0.001115398,0.01375982],"study_design_scores_gemma":[0.9574639,0.03978591,0.0009972173,0.00004285433,0.0004556422,0.00002643943,0.00002176392,0.0003324917,0.000175173,0.0001703575,0.0005127273,0.00001546107],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983692,0.007222032,0.0006300027,0.001227119,0.001140878,0.002297174,0.001136773,0.0001649089,0.002489161],"genre_scores_gemma":[0.9833907,0.003310555,0.001480596,0.001858167,0.0005845648,0.002813015,0.001333601,0.00004300612,0.005185777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006675555,"threshold_uncertainty_score":0.02233189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06751625483083432,"score_gpt":0.3841724924556876,"score_spread":0.3166562376248533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}